Aditxt, Inc.
ADTX · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Takeover Time 2026 LLC: Form 4
Insider disclosure · Filed · Report period 23 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q1 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001726711 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ADTX on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 737 N. Fifth Street, Suite 200, Richmond, VA, 23219
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- ADiTx Therapeutics, Inc. (to 06 Jul 2021), Aditx Therapeutics, Inc. (to 06 Jul 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields